Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation
Abroad (travel likely)RecruitingPHASE2
Conditions
Non-proliferative Diabetic Retinopathy (NPDR) · Open-angle Glaucoma (OAG) · Normal Tension Glaucoma (NTG)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Stanford University, Dept. of Ophthalmology, Palo Alto, California, United States
Study leads
Barbara M Wirostko, MD
Study Director
Qlaris Bio